AZNAX
Price
$11.38
Change
-$0.00 (-0.00%)
Updated
Aug 7 closing price
Net Assets
4.7B
RLBCX
Price
$36.79
Change
-$0.02 (-0.05%)
Updated
Aug 7 closing price
Net Assets
253.12B
Interact to see
Advertisement

AZNAX vs RLBCX

Header iconAZNAX vs RLBCX Comparison
Open Charts AZNAX vs RLBCXBanner chart's image
Virtus Income & Growth A
Price$11.38
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets4.7B
American Funds American Balanced R3
Price$36.79
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets253.12B
AZNAX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AZNAX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNAX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. AZNAX (4.7B). AZNAX pays higher dividends than RLBCX: AZNAX (2.26) vs RLBCX (1.56). AZNAX was incepted earlier than RLBCX: AZNAX (18 years) vs RLBCX (23 years). AZNAX (1.14) is less costly to investors than RLBCX (0.89). AZNAX is a more actively managed with annual turnover of: 61.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than AZNAX: RLBCX (250) vs AZNAX (2500). RLBCX annual gain was more profitable for investors over the last year : 11.04 vs. AZNAX (8.67). RLBCX return over 5 years is better than : 34.79 vs. AZNAX (8.64).
AZNAXRLBCXAZNAX / RLBCX
Total Expense Ratio1.140.89128%
Annual Report Gross Expense Ratio1.140.89128%
Fund Existence18 years23 years-
Gain YTD3.1198.35937%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.7B253B2%
Annual Yield % from dividends2.261.56146%
Returns for 1 year8.6711.0479%
Returns for 3 years10.6029.8436%
Returns for 5 years8.6434.7925%
Returns for 10 years16.7460.6528%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAWN6.030.23
+3.97%
Day One Biopharmaceuticals
HELE21.99-0.23
-1.04%
Helen of Troy Limited
FDS386.67-5.24
-1.34%
Factset Research Systems
ASTC5.35-0.25
-4.47%
Astrotech Corp
MSPR0.74-0.08
-10.14%
MSP Recovery Inc